VEON Balance Sheet Health
Financial Health criteria checks 2/6
VEON has a total shareholder equity of $1.3B and total debt of $3.3B, which brings its debt-to-equity ratio to 261.2%. Its total assets and total liabilities are $7.5B and $6.2B respectively. VEON's EBIT is $1.1B making its interest coverage ratio 2.7. It has cash and short-term investments of $1.6B.
Key information
261.2%
Debt to equity ratio
US$3.33b
Debt
Interest coverage ratio | 2.7x |
Cash | US$1.63b |
Equity | US$1.27b |
Total liabilities | US$6.22b |
Total assets | US$7.50b |
Recent financial health updates
Recent updates
It's A Story Of Risk Vs Reward With VEON Ltd. (NASDAQ:VEON)
May 03Here's Why VEON (NASDAQ:VEON) Has A Meaningful Debt Burden
Apr 15Veon notes third quarter boosting its 2022 revenue pace
Sep 16VEON: Waiting For The Explosive Catalyst Of Peace
Aug 16VEON's Banglalink signs tower sharing deal in Bangladesh
Aug 03Veon management boosts ownership via share awards
Jul 11VEON reports revenue growth 1.3% Y/Y for 5M22
Jun 29VEON: Value So Deep Otto Lidenbrock Wouldn't Find It
Mar 15These 4 Measures Indicate That VEON (NASDAQ:VEON) Is Using Debt Extensively
Mar 01VEON: A Reason For Optimism
Feb 09Is VEON Ltd. (NASDAQ:VEON) Potentially Undervalued?
Dec 28Here's Why VEON (NASDAQ:VEON) Has A Meaningful Debt Burden
Nov 15Upbeat VEON Q3 Earnings With Catalysts Kicking In
Oct 30Is VEON (NASDAQ:VEON) A Risky Investment?
Aug 16The Catalysts For A Higher VEON Valuation
Aug 11VEON makes AdTech acquisition in Russia
Jun 16Buy VEON's Crown Jewels On A Discount Now And Then Be Patient
Jun 01Financial Position Analysis
Short Term Liabilities: VEON's short term assets ($2.5B) do not cover its short term liabilities ($3.1B).
Long Term Liabilities: VEON's short term assets ($2.5B) do not cover its long term liabilities ($3.1B).
Debt to Equity History and Analysis
Debt Level: VEON's net debt to equity ratio (133.7%) is considered high.
Reducing Debt: VEON's debt to equity ratio has reduced from 378.4% to 261.2% over the past 5 years.
Debt Coverage: VEON's debt is well covered by operating cash flow (39%).
Interest Coverage: VEON's interest payments on its debt are not well covered by EBIT (2.7x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 02:34 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
VEON Ltd. is covered by 35 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Markus Bjerke | Arctic Securities ASA |
William Noel Milner | Arete Research Services LLP |
Jonathan Dann | Barclays |